A61P 5/00

Technology



back to "A61P 5/00" profile

More Results

Showing 1 to 20 of 40 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9815876 Chimeric inhibitor molecules of complement activationMar 04, 11Nov 14, 17OMEROS CORPORATION, KOBENHAVNS UNIVERSITET,
9708311 Benzimidazole derivatives as EP4 antagonistsDec 03, 13Jul 18, 17BAYER PHARMA AKTIENGESELLSCHAFT
9605046 Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related MethodsNov 07, 12Mar 28, 17The Scripps Research Institute
9603832 Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Mar 28, 17NEWRON PHARMACEUTICALS S.P.A.
9550822 ACTH prophylactic treatment of renal disordersJun 24, 14Jan 24, 17RHODE ISLAND HOSPITAL, MALLINCKRODT ARD IP LIMITED,
9314509 Pharmaceutical compositions of melanocortin receptor ligandsNov 15, 10Apr 19, 16IPSEN PHARMA S.A.S.
9283235 Intermittent lowering of cortisol as treatment of clinical conditions associated with abnormal concentrations of cortisol in animalsApr 09, 02Mar 15, 16STEGRAM PHARMACEUTICALS LIMITED
9173843 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugsJun 30, 09Nov 03, 15JESALIS PHARMA GMBH
9079970 Methods and compositions for specific modulation of MCL-1Dec 09, 09Jul 14, 15DANA-FARBER CANCER INSTITUTE, INC.
9080197 Equol level regulatorNov 02, 06Jul 14, 15KABUSHIKI KAISHA YAKULT HONSHA
8987315 Metalloenzyme inhibitor compoundsDec 29, 10Mar 24, 15INNOCRIN PHARMACEUTICALS, INC.
8957053 Proliposomal testosterone formulationsJan 07, 14Feb 17, 15WESTERN UNIVERSITY OF HEALTH SCIENCES, TESORX PHARMA, LLC.,
8822654 Mutated antithrombins, a process for preparing the same and their use as drugsJan 15, 10Sep 02, 14ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, UNIVERSITE PARIS-SUD, UNIVERSITE PARIS DESCARTES, Universite Paris—Sud XI,
8796416 ACTH prophylactic treatment of renal disordersOct 25, 11Aug 05, 14RHODE ISLAND HOSPITAL, MALLINCKRODT ARD IP LIMITED,
8754037 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameDec 21, 11Jun 17, 14HANALL BIOPHARMA CO., LTD.
8691275 Controlled-release melatonin compositions and related methodsJan 27, 12Apr 08, 14Physician's Seal, LLC
8691752 Protein product for treatment of infectious diseases and related inflammatory processesMar 27, 08Apr 08, 14UNIVERSITAT DE BARCELONA
8658623 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulatorsJul 16, 13Feb 25, 14ALLERGAN, INC.
8653050 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulatorsJul 08, 13Feb 18, 14ALLERGAN, INC.
8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameDec 21, 11Dec 31, 13HANALL BIOPHARMA CO., LTD.

Showing 1 to 20 of 40 results